NasdaqCM - Delayed Quote USD
CalciMedica, Inc. (CALC)
1.7150
+0.0650
+(3.94%)
At close: June 4 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.53 | -0.5 | -0.35 | -0.3 |
| EPS Actual | -0.36 | -0.5 | -1.22 | -0.36 |
| Difference | 0.17 | -0 | -0.87 | -0.06 |
| Surprise % | 31.65% | -0.67% | -246.10% | -20.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CALC | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/4/2025 |
| Initiated | LUCID CAPITAL MARKETS: Buy | 12/17/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/4/2024 |
Related Tickers
PMVP PMV Pharmaceuticals, Inc.
0.9300
+1.16%
ANTX AN2 Therapeutics, Inc.
1.0900
-0.91%
GRTX Galera Therapeutics, Inc.
0.0236
-8.88%
DMN.MU Diamyd Medical AB
0.8910
+7.48%
LIXT Lixte Biotechnology Holdings, Inc.
1.3900
-1.42%
SPRB Spruce Biosciences, Inc.
0.0602
-7.38%
BOLT Bolt Biotherapeutics, Inc.
0.3238
+6.69%
NXTC NextCure, Inc.
0.4731
-0.13%
KZR Kezar Life Sciences, Inc.
4.2600
-2.96%
IVBIY Innovent Biologics Inc.
29.00
+11.07%